Peter Flachenecker

6.1k citations
152 papers · 4.9k · 1 hit paper · h-index 36

Impact in

Papers in

Peter Flachenecker

134 papers receiving 4.5k citations

Peter Flachenecker's Hit Papers

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension 2018 · 286 citations
2860+2+5Years since publication50100150200250

Peers

Peter Flachenecker
Comparison fields: 5 of 111
  • Pathology and Forensic Medicine 3.1k
  • Neurology 565
  • Physical Therapy, Sports Therapy and Rehabilitation 143
  • Pharmacology 224
  • Neurology 109
Replace Claudio Marcello Solaro with:
Claudio Marcello Solaro Italy
Nicholas G. LaRocca United States
Martin Marziniak Germany
Zaza Katsarava Germany
Sarah Anne Morrow Canada
Vahid Shaygannejad Iran
Giuseppe Orefice Italy
SHARON G. LYNCH United States
Christopher Christodoulou United States
Richard T. Linn United States
Peter Flachenecker relative to Claudio Marcello Solaro Italy Claudio Marcello Solaro's profile →
Citations per field
00.5×1.6×
Claudio Marcello Solaro · 1×
Citations per year

Countries citing papers authored by Peter Flachenecker

Since Specialization
Citations

This map shows the geographic impact of Peter Flachenecker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Flachenecker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Flachenecker more than expected).

Fields of papers citing papers by Peter Flachenecker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Flachenecker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Flachenecker. The network helps show where Peter Flachenecker may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Flachenecker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Flachenecker Line = papers co-authored together Peter Flachenecker links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 152 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2002530
2 2001410
3
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension
Hit paper breakdown →
2018286
4 2007172
5 2004140
6 2014136
7 2001130
8 2018122
9 1997109
10 2003108
11 2005108
12 2005105
13 199998
14 200598
15 201398
16 200589
17 200981
18 200880
19 200668
20 201767

About Peter Flachenecker

Peter Flachenecker is a scholar working on Pathology and Forensic Medicine, Neurology, Urology, Physical Therapy, Sports Therapy and Rehabilitation and Family Practice, having authored 152 papers that have together received 4.9k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (111 papers), Heart Rate Variability and Autonomic Control (9 papers), Botulinum Toxin and Related Neurological Disorders (8 papers), Peripheral Neuropathies and Disorders (7 papers), Urinary Bladder and Prostate Research (6 papers), Cardiovascular Syncope and Autonomic Disorders (5 papers), Cannabis and Cannabinoid Research (5 papers) and Medical research and treatments (5 papers). The work is most often cited by research in Pathology and Forensic Medicine (3.1k citations), Neurology (565 citations), Physical Therapy, Sports Therapy and Rehabilitation (143 citations), Pharmacology (224 citations) and Neurology (109 citations). Peter Flachenecker has collaborated with scholars based in Germany, Austria and Spain. Frequent co-authors include Uwe Klaus Zettl, Karlheinz Reiners, Klaus Victor Toyka, Thomas Henze, Marlene Gottschalk, Claudia Trenkwalder, Tania Kümpfel, Klaus Viktor Toyka, Boris A. Kallmann and Oliver Martin Grauer. Their work appears in journals such as Multiple Sclerosis Journal, Journal of Neurology, Multiple Sclerosis and Related Disorders, Health and Quality of Life Outcomes and Acta Neurologica Scandinavica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact